Article info
PDFClinical science
Cost-effectiveness analysis of preloaded versus non-preloaded Descemet membrane endothelial keratoplasty for the treatment of Fuchs endothelial corneal dystrophy in an academic centre
- Correspondence to Dr Ula Jurkunas, Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA; Myriam.Boehm{at}gmail.com
Citation
Cost-effectiveness analysis of preloaded versus non-preloaded Descemet membrane endothelial keratoplasty for the treatment of Fuchs endothelial corneal dystrophy in an academic centre
Publication history
- Received July 19, 2020
- Revised January 19, 2021
- Accepted February 5, 2021
- First published February 26, 2021.
Online issue publication
June 28, 2023
Article Versions
- Previous version (28 June 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.